Advanced Renal Cell Carcinoma Completed Phase 2 Trials for Panitumumab (DB01269)

Also known as: Advanced Renal cell carcinoma

IndicationStatusPhase
DBCOND0032596 (Advanced Renal Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00425204Study for Patients Who Have Benefited and Tolerated Prior Panitumumab TreatmentTreatment
NCT00425035Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2Treatment